Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Prime Medicine, Inc. - Common Stock (NQ:PRME)

1.180 -0.080 (-6.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Prime Medicine, Inc. - Common Stock

< Previous 1 2 3 Next >
Citi Downgrade Sparks Retail Chatter On Prime Medicine Amid Cash Runway Uncertainty
The biotech firm announced a restructuring to focus on its liver disease programs while cutting costs and workforce amid ongoing development challenges. 
Via Stocktwits
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
6 Analysts Assess Prime Medicine: What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Prime Medicine Announces Layoffs, CEO Transition: Retail Gets More Bullish
The company said Keith Gottesdiener will step down as the chief executive, while CFO Allan Reine will succeed him. 
Via Stocktwits
Topics Workforce
Exposures Layoff
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics
On April 11th, 2025, Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses. 
Via Benzinga
Why Prime Medicine Stock Was Climbing Higher This Week
Via The Motley Fool
Why Prime Medicine Stock Is Soaring Today
Via The Motley Fool
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta
Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx. 
Via Benzinga
12 High-Growth Stocks That Could Deliver Parabolic Returns
These 12 innovative companies could deliver exponential returns over the next quarter century. 
Via The Motley Fool
Why I Keep Buying These 14 Incredible Growth Stocks
This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Changes are afoot at the company, and investors welcomed them. 
Via The Motley Fool
Dow Dips 300 Points; Emcore Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday
Via Benzinga
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
Prime Medicine enters a strategic collaboration with Bristol Myers Squibb to develop next-gen T-cell therapies, securing $110 million upfront with potential for $3.5 billion in milestones. The company... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
2 Growth Stocks That Could Make You Richer
Discover two cutting-edge growth stocks that could revolutionize medicine and space exploration. 
Via The Motley Fool
PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024
PRME stock results show that Prime Medicine missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy. 
Via InvestorPlace
Exposures Product Safety
Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio
Alphabet may have strong insight into both company's industries. 
Via The Motley Fool
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential. 
Via InvestorPlace
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. 
Via InvestorPlace
PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024
PRME stock results show that Prime Medicine beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday! 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.